Shuttle Pharmaceuticals Holdings (SHPH) Gains from Investment Securities (2021 - 2022)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Gains from Investment Securities came in at $492700.0 in Q4 2022, up 34.64% year-on-year from $365926.0 in Q4 2021, and up 536.8% quarter-over-quarter from -$112797.0 in Q3 2022.

Shuttle Pharmaceuticals Holdings (SHPH) Gains from Investment Securities (2021 - 2022) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $492700.0 for Q4 2022.

  • On a quarterly basis, Gains from Investment Securities rose 34.64% year-over-year to $492700.0 in Q4 2022; TTM through Dec 2022 was $772514.0, a N/A change from a year earlier, with the FY2023 full-year figure at $1.3 million, up 223.21% from the prior year.
  • Gains from Investment Securities grew to $492700.0 in Q4 2022 per SHPH's latest filing, from -$112797.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $492700.0 in Q4 2022 and bottomed at -$112797.0 in Q3 2022.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.51 Bn 87.64 Bn -
2 Teva Pharmaceutical Industries 36.00 Bn 32.26 Bn 1.97 Bn
3 Zoetis 32.61 Bn 30.67 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn
5 United Therapeutics 23.05 Bn 20.90 Bn 648.10 Mn
6 RedHill Biopharma 21.48 Bn 21.48 Bn -
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn
10 Shuttle Pharmaceuticals Holdings 1.45 Mn 1.45 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 492,700.00
Dec 31, 2022 492,700.00
Sep 30, 2022 -112,797.00
Sep 30, 2022 -112,797.00
Dec 31, 2021 365,926.00
Dec 31, 2021 365,926.00
Sep 30, 2021 26,685.00
Sep 30, 2021 26,685.00